d-alpha tocopherol has been researched along with Cardiac Arrest, Sudden in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, DZ; Dai, Y; Jia, N; Li, N | 1 |
| Eidelman, RS; Hebert, PR; Hennekens, CH; Hollar, D; Lamas, GA | 1 |
| Bosch, J; Dagenais, G; Mitchell, LB; Pogue, J; Teo, KK; Yusuf, S | 1 |
| Erdmann, E; Hoppe, UC | 1 |
| Garewal, HS; Hoffman, RM | 1 |
| de Lorgeril, M; Defaye, P; Mabo, P; Paillard, F; Salen, P | 1 |
| Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S | 1 |
3 review(s) available for d-alpha tocopherol and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease.
Topics: Adult; Aged; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Vitamin E | 2004 |
[Cardiology -- what is new?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Blood Pressure Monitoring, Ambulatory; Cardiology; Cardiovascular Diseases; Death, Sudden, Cardiac; Humans; Pacemaker, Artificial; Primary Prevention; Stem Cell Transplantation; Stents; Vitamin E | 2005 |
Dietary prevention of sudden cardiac death.
Topics: Alcohol Drinking; Animals; Antioxidants; Coronary Disease; Death, Sudden, Cardiac; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Humans; Oleic Acid; Vitamin E | 2002 |
2 trial(s) available for d-alpha tocopherol and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Double-Blind Method; Female; Follow-Up Studies; Heart Arrest; Humans; Life Tables; Male; Middle Aged; Neurotransmitter Agents; Ramipril; Risk; Survival Analysis; Treatment Outcome; Vitamin E | 2004 |
Alpha-tocopherol supplementation for men with existing coronary artery disease: a feasibility study.
Topics: Aged; Analysis of Variance; Antioxidants; Coronary Disease; Death, Sudden, Cardiac; Feasibility Studies; Follow-Up Studies; Humans; Lipids; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Recurrence; Thiobarbituric Acid Reactive Substances; Veterans; Vitamin E | 1999 |
2 other study(ies) available for d-alpha tocopherol and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Endothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKCepsilon.
Topics: Animals; Antioxidants; Biomarkers, Pharmacological; Calcium; Death, Sudden, Cardiac; Down-Regulation; Endothelin Receptor Antagonists; Gene Expression Regulation; Heart Failure; Myocytes, Cardiac; Phosphorylation; Protein Kinase C-epsilon; Pyrazoles; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tacrolimus Binding Proteins; Vitamin E | 2008 |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E | 2002 |